Increasing Minority Participation in Clinical Research

Simple item page
dc.contributor.authorAgodoa, Lawrence
dc.contributor.authorAlanis, Alfonso J.
dc.contributor.authorAlexander-Bridges, Maria
dc.contributor.authorDoan, Loretta L.
dc.contributor.authorFleming, G. Alexander
dc.contributor.authorGetz, Ken
dc.contributor.authorGibbs, Brian K.
dc.contributor.authorProthrow-Stith, Deborah
dc.date.accessioned2019-08-14T15:04:55Z
dc.date.available2019-08-14T15:04:55Z
dc.date.issued2007
dc.description.abstractOur goal is to ensure that clinical research supporting 1) the safety and efficacy of products for labeling purposes and 2) the validity of biomarkers commonly used to assess risk and to design therapeutic strategies is based on data sufficient for statistical power and derived from diverse subpopulations. It is widely recognized that data supporting therapeutic options for women and minorities have been deficient because these groups were not previously included in clinical trials. Although the combined efforts of Congress, the Office of Women’s Health at the Food and Drug Administration (FDA), and the Office of Research on Women’s Health…
dc.identifierhttps://doi.org/10.13016/i62b-gudm
dc.identifier.citationAgodoa, Lawrence and Alanis, Alfonso J. and Alexander-Bridges, Maria and Doan, Loretta L. and Fleming, G. Alexander and Getz, Ken and Gibbs, Brian K. and Prothrow-Stith, Deborah The Endocrine Society (2007) Increasing Minority Participation in Clinical Research. Discussion Paper. UNSPECIFIED.
dc.identifier.otherEprint ID 3209
dc.identifier.urihttp://hdl.handle.net/1903/23812
dc.subjectHealth Equity
dc.subjectPharmacotherapy
dc.subjectPolicy
dc.subjectResearch
dc.subjectGenetics and Race
dc.titleIncreasing Minority Participation in Clinical Research
dc.typeTechnical Report

Files

Collections

Minority Health and Health Equity Archive